Steve Nicholson

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

J. Blake Bartlett, A Michael, Ian Clarke et al. · British Journal of Cancer · 2004 · 139 citations · Full text

Immunology, Pathology, Revimid Trade Mark +16

Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

Steve Nicholson, Emma Hall, S.J. Harland et al. · British Journal of Cancer · 2013 · 132 citations · Full text

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study

Pippa Corrie, Andrea Marshall, Janet Dunn et al. · The Lancet Oncology · 2014 · 109 citations · Full text

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

Tim Eisen, Heikki Joensuu, Paul Nathan et al. · The Lancet Oncology · 2012 · 108 citations · Full text

Urology, Oncology, Genitourinary Cancer +6

Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.

Steve Nicholson, Calvin S. R. Gooden, V Hird et al. · Oncology Reports · 1998 · 83 citations